Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 12:52PM ET
5.31
Dollar change
+0.14
Percentage change
2.71
%
Index- P/E- EPS (ttm)-3.32 Insider Own3.00% Shs Outstand30.32M Perf Week5.36%
Market Cap162.22M Forward P/E- EPS next Y-0.14 Insider Trans0.00% Shs Float29.63M Perf Month-35.64%
Income-100.12M PEG- EPS next Q-0.01 Inst Own69.45% Short Float5.93% Perf Quarter-15.31%
Sales141.30M P/S1.15 EPS this Y87.68% Inst Trans-1.84% Short Ratio9.21 Perf Half Y-29.95%
Book/sh-0.14 P/B- EPS next Y66.67% ROA-26.37% Short Interest1.76M Perf Year59.94%
Cash/sh0.62 P/C8.50 EPS next 5Y10.00% ROE-116.16% 52W Range3.09 - 11.45 Perf YTD-14.22%
Dividend Est.- P/FCF- EPS past 5Y- ROI-68.64% 52W High-53.64% Beta1.03
Dividend TTM- Quick Ratio1.35 Sales past 5Y-20.21% Gross Margin19.62% 52W Low72.12% ATR (14)0.47
Dividend Ex-Date- Current Ratio2.39 EPS Y/Y TTM-0.70% Oper. Margin-17.42% RSI (14)28.67 Volatility7.44% 6.05%
Employees459 Debt/Eq3.21 Sales Y/Y TTM-60.64% Profit Margin-70.86% Recom3.00 Target Price8.00
Option/ShortYes / Yes LT Debt/Eq3.16 EPS Q/Q-52.57% Payout- Rel Volume0.87 Prev Close5.17
Sales Surprise- EPS Surprise- Sales Q/Q-33.76% Earnings- Avg Volume190.77K Price5.31
SMA20-23.92% SMA50-26.79% SMA200-32.19% Trades Volume89,472 Change2.71%
Date Action Analyst Rating Change Price Target Change
Mar-20-23Downgrade Stephens Overweight → Equal-Weight $11 → $2
Mar-26-24 04:30PM
Mar-21-24 12:40PM
Mar-20-24 07:30AM
07:00AM
Feb-16-24 04:05PM
09:49AM Loading…
Feb-06-24 09:49AM
Jan-30-24 12:20AM
Jan-12-24 04:43PM
Jan-08-24 03:05AM
Jan-05-24 08:00AM
Dec-13-23 07:30AM
Nov-20-23 04:05PM
Nov-17-23 06:04PM
Oct-24-23 07:48AM
Oct-18-23 04:05PM
05:00AM Loading…
Oct-17-23 05:00AM
Oct-10-23 04:05PM
08:43AM
Sep-28-23 10:00AM
Sep-01-23 10:44AM
Aug-31-23 10:15PM
08:50AM
07:54AM
07:30AM
Aug-22-23 04:06PM
04:05PM
Aug-18-23 06:30PM
Aug-17-23 08:15AM
Aug-16-23 01:02AM
Aug-12-23 12:33AM
05:08AM Loading…
Jul-31-23 05:08AM
Jul-22-23 08:19AM
Jul-12-23 08:48AM
Jul-07-23 11:40AM
Jun-29-23 06:37AM
Jun-08-23 07:30AM
Jun-03-23 08:13AM
Jun-02-23 01:53AM
Jun-01-23 07:23AM
07:15AM
May-26-23 06:20AM
May-22-23 04:51PM
04:49PM
06:55AM
Apr-17-23 07:26AM
Apr-14-23 04:35PM
Apr-11-23 02:25AM
Apr-06-23 04:05PM
Mar-17-23 09:53PM
Mar-16-23 04:24PM
04:23PM
04:21PM
Feb-16-23 08:22AM
Feb-07-23 04:30PM
Jan-12-23 08:01AM
Jan-11-23 04:35PM
Jan-09-23 04:05PM
Dec-28-22 12:17PM
Dec-23-22 07:29AM
Dec-08-22 05:26AM
Nov-25-22 04:50PM
Nov-17-22 01:17PM
Nov-15-22 08:30AM
Lifecore Biomedical, Inc. is a contract development and manufacturing organization, which engages in the provision of differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It operates through the following business segments: Lifecore, Curation Foods, and Others. The Lifecore segment focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The Curation Foods segment is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels. The Others segment is Corporate, which includes corporate general and administrative expenses, Non Lifecore and non-Curation Food interest income, interest expense, and income tax expenses. The company was founded by Ray Stewart on October 31, 1986 and is headquartered in Chaska, MN.